Long-term remission of a Her2/neu positive primary breast cancer under double monoclonal antibody therapy with trastuzumab and bevacizumabRobert Königsberg, Christian Dittrich, Julia Maierhofer et al.|Radiology and Oncology|2013Cited by 8